Sanofi SA (SNY)
49.54
+0.31
(+0.63%)
USD |
NASDAQ |
May 01, 14:08
Sanofi Market Cap: 123.67B for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 30, 2024 | 122.90B |
| April 29, 2024 | 122.55B |
| April 26, 2024 | 122.65B |
| April 25, 2024 | 123.22B |
| April 24, 2024 | 116.36B |
| April 23, 2024 | 119.06B |
| April 22, 2024 | 117.71B |
| April 19, 2024 | 115.59B |
| April 18, 2024 | 113.31B |
| April 17, 2024 | 115.11B |
| April 16, 2024 | 114.34B |
| April 15, 2024 | 115.44B |
| April 12, 2024 | 114.66B |
| April 11, 2024 | 116.33B |
| April 10, 2024 | 117.66B |
| April 09, 2024 | 118.66B |
| April 08, 2024 | 117.71B |
| April 05, 2024 | 117.96B |
| April 04, 2024 | 119.33B |
| April 03, 2024 | 119.73B |
| April 02, 2024 | 119.08B |
| April 01, 2024 | 120.55B |
| March 28, 2024 | 121.33B |
| March 27, 2024 | 123.67B |
| March 26, 2024 | 124.20B |
| Date | Value |
|---|---|
| March 25, 2024 | 123.42B |
| March 22, 2024 | 120.00B |
| March 21, 2024 | 119.16B |
| March 20, 2024 | 120.40B |
| March 19, 2024 | 118.53B |
| March 18, 2024 | 119.41B |
| March 15, 2024 | 120.55B |
| March 14, 2024 | 120.05B |
| March 13, 2024 | 120.43B |
| March 12, 2024 | 120.98B |
| March 11, 2024 | 120.70B |
| March 08, 2024 | 120.45B |
| March 07, 2024 | 119.98B |
| March 06, 2024 | 119.03B |
| March 05, 2024 | 118.58B |
| March 04, 2024 | 117.71B |
| March 01, 2024 | 118.06B |
| February 29, 2024 | 119.46B |
| February 28, 2024 | 119.86B |
| February 27, 2024 | 120.39B |
| February 26, 2024 | 120.36B |
| February 23, 2024 | 121.78B |
| February 22, 2024 | 119.36B |
| February 21, 2024 | 119.66B |
| February 20, 2024 | 116.99B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
93.35B
Minimum
Sep 27 2022
143.50B
Maximum
Apr 11 2022
122.48B
Average
124.04B
Median
Market Cap Benchmarks
| AstraZeneca PLC | 236.69B |
| GSK PLC | 86.57B |
| Novo Nordisk A/S | 575.78B |
| Regeneron Pharmaceuticals Inc | 98.60B |
| Biophytis SA | 2.607M |
Market Cap Related Metrics
| PE Ratio | 25.04 |
| PS Ratio | 2.446 |
| Price to Book Value | 1.511 |
| Price | 49.54 |
| Earnings Yield | 3.99% |
| Operating PE Ratio | 11.65 |
| Normalized PE Ratio | 16.74 |